PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33261317-9 2020 QUIN exposure down-regulated CREB, BDNF, and synaptic protein expression in neurons. Quinolinic Acid 0-4 brain derived neurotrophic factor Homo sapiens 35-39 32408403-4 2020 In this study, we transplanted BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) into the contra-lateral side of unilateral quinolinic acid (QA)-lesioned striatum of HD rat model. Quinolinic Acid 132-147 brain derived neurotrophic factor Homo sapiens 31-35 32408403-4 2020 In this study, we transplanted BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) into the contra-lateral side of unilateral quinolinic acid (QA)-lesioned striatum of HD rat model. Quinolinic Acid 149-151 brain derived neurotrophic factor Homo sapiens 31-35 11150327-5 2001 Intrastriatal injection of quinolinate, kainate, 3-nitropropionic acid, or colchicine increased BDNF mRNA levels in cerebral cortex. Quinolinic Acid 27-38 brain derived neurotrophic factor Homo sapiens 96-100 10964490-0 2000 Developmental regulation of BDNF and NT-3 expression by quinolinic acid in the striatum and its main connections. Quinolinic Acid 56-71 brain derived neurotrophic factor Homo sapiens 28-32 10964490-2 2000 Here we have measured changes in the developmental expression pattern of BDNF and NT-3 in the striatum, cortex, and substantia nigra induced by intrastriatal injection of the N-methyl-d-aspartate glutamate receptor agonist quinolinic acid (QUIN). Quinolinic Acid 223-238 brain derived neurotrophic factor Homo sapiens 73-77 10964490-2 2000 Here we have measured changes in the developmental expression pattern of BDNF and NT-3 in the striatum, cortex, and substantia nigra induced by intrastriatal injection of the N-methyl-d-aspartate glutamate receptor agonist quinolinic acid (QUIN). Quinolinic Acid 240-244 brain derived neurotrophic factor Homo sapiens 73-77 10825501-4 2000 In particular, BDNF prevents cell death of certain striatal populations in excitotoxic models of Huntington disease (HD) following intrastriatal injection of quinolinic acid to the adult rodent brain. Quinolinic Acid 158-173 brain derived neurotrophic factor Homo sapiens 15-19 20974202-3 2010 To test this possibility, we first performed a previous insult with quinolinic acid (QA) to specifically damage the striatal GABAergic neuronal cell bodies in order to remove the nigral BDNF target. Quinolinic Acid 68-83 brain derived neurotrophic factor Homo sapiens 186-190 20974202-3 2010 To test this possibility, we first performed a previous insult with quinolinic acid (QA) to specifically damage the striatal GABAergic neuronal cell bodies in order to remove the nigral BDNF target. Quinolinic Acid 85-87 brain derived neurotrophic factor Homo sapiens 186-190 18323792-0 2008 AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Quinolinic Acid 33-48 brain derived neurotrophic factor Homo sapiens 4-8 18323792-2 2008 In this study we demonstrate that overexpression of BDNF in the striatum attenuates motor impairment and reduces the extent of striatal damage following quinolinic acid lesioning. Quinolinic Acid 153-168 brain derived neurotrophic factor Homo sapiens 52-56